The role of heart rate reduction in angina management and beyond.
This article highlights the significance of heart rate as an independent risk factor and prognostic marker for cardiovascular disease and examines the pharmacological measures available that lead to effective heart rate reduction.
Izzat
Lena Marie
LM
Cardiology Department, Prince Philip Hospital, Llanelli SA14 8DR.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy*; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D000077550:Ivabradine; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D001552:Benzazepines; D002316:Cardiotonic Agents; D000077550:Ivabradine